[64Cu]FBP8
N/A
Report date: 2026/05/06 20:02:28
NME
Base Information
Drug Name[64Cu]FBP8
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A
Develop Information
Active CompaniesThe Brigham and Women's HospitalMassachusetts General Hospital
Inactive CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)
Active Indications +[10]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A